Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885178982> ?p ?o ?g. }
- W2885178982 endingPage "6476" @default.
- W2885178982 startingPage "6463" @default.
- W2885178982 abstract "Although limited by severe side effects and development of resistance, platinum-based therapies still represent the most common first-line treatment for non-small cell lung cancer (NSCLC). However, a crucial need in the clinical management of NSCLC is represented by the identification of cases sensitive to DNA damage response (DDR)-targeting drugs, such as cisplatin or PARP inhibitors. Here, we provide a molecular rationale for the stratification of NSCLC patients potentially benefitting from platinum compounds based on the expression levels of RANBP9, a recently identified player of the cellular DDR. RANBP9 was found overexpressed by immunohistochemistry (IHC) in NSCLC compared to normal adjacent tissues (NATs) (n = 147). Moreover, a retrospective analysis of 132 platinum-treated patients from the multi-centric TAILOR trial showed that RANBP9 overexpression levels are associated with clinical response to platinum compounds [Progression Free Survival Hazard Ratio (RANBP9 high vs low) 1.73, 95% CI 1.15-2.59, p = 0.0084; Overall Survival HR (RANBP9 high vs low) 1.99, 95% CI 1.27-3.11, p = 0.003]. Accordingly, RANBP9 KO cells showed higher sensitivity to cisplatin in comparison with WT controls both in vitro and in vivo models. NSCLC RANBP9 KO cells were also more sensitive than control cells to the PARP inhibitor olaparib alone and in combination with cisplatin, due to defective ATM-dependent and hyper-activated PARP-dependent DDR. The current investigation paves the way to prospective studies to assess the clinical value of RANBP9 protein levels as prognostic and predictive biomarker of response to DDR-targeting drugs, leading to the development of new tools for the management of NSCLC patients." @default.
- W2885178982 created "2018-08-22" @default.
- W2885178982 creator A5002813181 @default.
- W2885178982 creator A5003934794 @default.
- W2885178982 creator A5007427257 @default.
- W2885178982 creator A5014332528 @default.
- W2885178982 creator A5016191595 @default.
- W2885178982 creator A5018517679 @default.
- W2885178982 creator A5019771690 @default.
- W2885178982 creator A5020407484 @default.
- W2885178982 creator A5027149352 @default.
- W2885178982 creator A5029365451 @default.
- W2885178982 creator A5030262791 @default.
- W2885178982 creator A5043350645 @default.
- W2885178982 creator A5046301295 @default.
- W2885178982 creator A5046342653 @default.
- W2885178982 creator A5047481473 @default.
- W2885178982 creator A5049996919 @default.
- W2885178982 creator A5053162229 @default.
- W2885178982 creator A5059652753 @default.
- W2885178982 creator A5060760341 @default.
- W2885178982 creator A5074436993 @default.
- W2885178982 creator A5079700663 @default.
- W2885178982 creator A5089499956 @default.
- W2885178982 creator A5091509029 @default.
- W2885178982 creator A5091714925 @default.
- W2885178982 date "2018-08-03" @default.
- W2885178982 modified "2023-10-03" @default.
- W2885178982 title "RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients" @default.
- W2885178982 cites W1523531555 @default.
- W2885178982 cites W1964388201 @default.
- W2885178982 cites W1965119859 @default.
- W2885178982 cites W1970184435 @default.
- W2885178982 cites W1973268287 @default.
- W2885178982 cites W1973268693 @default.
- W2885178982 cites W1978111771 @default.
- W2885178982 cites W1982957001 @default.
- W2885178982 cites W1989123634 @default.
- W2885178982 cites W2007100907 @default.
- W2885178982 cites W2009007206 @default.
- W2885178982 cites W2016004402 @default.
- W2885178982 cites W2028018692 @default.
- W2885178982 cites W2036385968 @default.
- W2885178982 cites W2037202852 @default.
- W2885178982 cites W2050142910 @default.
- W2885178982 cites W2055430648 @default.
- W2885178982 cites W2068015716 @default.
- W2885178982 cites W2090576862 @default.
- W2885178982 cites W2091070104 @default.
- W2885178982 cites W2097026987 @default.
- W2885178982 cites W2098737737 @default.
- W2885178982 cites W2110177539 @default.
- W2885178982 cites W2126158121 @default.
- W2885178982 cites W2130177169 @default.
- W2885178982 cites W2134640949 @default.
- W2885178982 cites W2138714093 @default.
- W2885178982 cites W2156607330 @default.
- W2885178982 cites W2168150041 @default.
- W2885178982 cites W2172631200 @default.
- W2885178982 cites W2177617854 @default.
- W2885178982 cites W2179105349 @default.
- W2885178982 cites W2288855221 @default.
- W2885178982 cites W2288894747 @default.
- W2885178982 cites W2291134671 @default.
- W2885178982 cites W2339289924 @default.
- W2885178982 cites W2339786129 @default.
- W2885178982 cites W2340761255 @default.
- W2885178982 cites W2344855029 @default.
- W2885178982 cites W2394884517 @default.
- W2885178982 cites W2465672002 @default.
- W2885178982 cites W2490662854 @default.
- W2885178982 cites W2559255020 @default.
- W2885178982 cites W2567163708 @default.
- W2885178982 cites W2589039930 @default.
- W2885178982 cites W2607970143 @default.
- W2885178982 cites W2608187361 @default.
- W2885178982 cites W2724321370 @default.
- W2885178982 cites W2743213992 @default.
- W2885178982 cites W2751249189 @default.
- W2885178982 cites W2762867620 @default.
- W2885178982 cites W2770609569 @default.
- W2885178982 cites W2805354595 @default.
- W2885178982 cites W4211006558 @default.
- W2885178982 cites W2192054982 @default.
- W2885178982 doi "https://doi.org/10.1038/s41388-018-0424-8" @default.
- W2885178982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6690599" @default.
- W2885178982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30076413" @default.
- W2885178982 hasPublicationYear "2018" @default.
- W2885178982 type Work @default.
- W2885178982 sameAs 2885178982 @default.
- W2885178982 citedByCount "14" @default.
- W2885178982 countsByYear W28851789822019 @default.
- W2885178982 countsByYear W28851789822020 @default.
- W2885178982 countsByYear W28851789822021 @default.
- W2885178982 countsByYear W28851789822022 @default.
- W2885178982 countsByYear W28851789822023 @default.
- W2885178982 crossrefType "journal-article" @default.
- W2885178982 hasAuthorship W2885178982A5002813181 @default.